ATYR (aTyr Pharma Inc) Sof foyda

ATYR (aTyr Pharma) - kompaniyaning tovar belgisi

aTyr Pharma, Inc. (ATYR) immun dori vositalarini ishlab chiqishga ESG tamoyillarini integratsiya qilgan holda, qat'iy biosafety nazoratini ta'minlamoqda. FDA tomonidan qo'llab-quvvatlanadigan sarkoidoz uchun tRNA terapiyasi ekotizimi sodiq bemorlar bazasini shakllantirmoqda. Sovuq zanjir transportiga sarflangan yuqori xarajatlar dori vositalarining yaxlitligini kafolatlaydi. Kompaniyaning foyda trayektoriyasi operatsion samaradorlikni namoyish etadi, bunda yakuniy ko'rsatkich qiymati -0.06 ga yetadi.

ATYR (aTyr Pharma, Inc.) Sof foyda tarixi 06.06.2024dan 30.10.2026gacha

aTyr Pharma (ATYR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari aTyr Pharmaceuticals|ATYR - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi aTyr Pharmaceuticals|ATYR - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati aTyr Pharma|ATYR - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi atyrpharma.com|ATYR - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati aTyr Pharma, Inc.|ATYR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati aTyr Pharma Inc|ATYR - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar aTyr Pharmaceuticals|ATYR - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi aTyr Pharma|Shoshilinch likvidlik atyrpharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ATYR - Sof foyda
Kompaniyaning jamlanma tahlili:aTyr Pharma, Inc.
aTyr asosiy tovari

Noyob o'pka patologiyalari uchun dori vositalarini ishlab chiqish klinik sinovlarga ulkan xarajatlarni talab qiladi, bu esa bevosita aTyr Pharma, Inc. (ATYR) kompaniyasining pul oqimi dinamikasini belgilaydi. Kompaniyaning sof operatsion foydasi barcha operatsion xarajatlar daromaddan chegirib tashlanganidan keyin qolgan yakuniy mablag'lar sifatida hisoblanadi va bu biznesning bozor sharoitlariga moslashish hamda loyihaning moliyaviy barqarorligini ta'minlash bo'yicha haqiqiy qobiliyatini aks ettiradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR (Nektar Therapeutics) - Sof daromad|UPB: Soliqlar to‘langandan keyingi foyda|Sof daromad ZBIO|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV (KalVista Corp) - Yakuniy foyda|Septerna Inc - Sof daromad|Yakuniy foyda PVLA|SVRA - Kompaniyaning sof foydasi|Soliqdan keyingi foyda RIGL|ANAB: Sof foyda|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|Sof foyda rapt.com|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Kyverna KYTX|TLSA - Sof daromad|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|THTX (Theratechnologies) - Sof daromad|Avalo Therapeutics, Inc. - Yakuniy foyda|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|zurabio.com - Kompaniya foydasi|Sof foyda ADAG (Adagene Inc.)|IMA - Sof daromad|STTK: Sof daromad|Sof moliyaviy natija Equillium, Inc. EQ|CNTB: Sof foyda|Immunic (IMUX) - Sof foyda|Sof daromad ATRA|IFRX (InflaRx GmbH) - Soliqlar to‘langandan keyingi foyda|Sof daromad XFOR (X4 Pharma)|ACET - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Celularity CELU|Yakuniy foyda INMB|BRNS - Kompaniyaning sof foydasi|Soliqdan keyingi foyda KZR|SABS: Sof foyda|Akari Therapeutics, Plc - Yakuniy foyda|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. - Yakuniy foyda|AIM (AIM ImmunoTech) - Sof foyda|Aditxt Corp (ADTX) - Sof moliyaviy natija|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB - Sof daromad|INDP: Sof daromad|SCNI - Sof foyda|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Kompaniya foydasi AFMD|ALLK (Allakos Inc) - Sof foyda|Kompaniyaning sof daromadi HOOKIPA HOOK|Sof foyda IGMS|Sof foyda iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Sof daromad|Soliqlar to‘langandan keyingi foyda TCBP (tcbiopharm.com)|THRD: Sof daromad